Pregnancy, maternal exposure to analgesic medicines, and leukemia in Brazilian children below 2 years of age

Childhood leukemia etiology, and mainly the interactions of genetic and environmental risk factors, remains largely unexplored. This national hospital-based case–control study was carried out in Brazil among children aged 0–23 months who were recruited at cancer and general hospitals in 13 states. M...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer prevention 2015-05, Vol.24 (3), p.245-252
Main Authors: Couto, Arnaldo C., Ferreira, Jeniffer D., Pombo-de-Oliveira, Maria S., Koifman, Sérgio
Format: Article
Language:English
Subjects:
Adolescent
Adult
Analgesics - adverse effects
Brazil - epidemiology
Case-Control Studies
Female
Humans
Infant
Infant, Newborn
Leukemia - chemically induced
Leukemia - diagnosis
Leukemia - epidemiology
Male
Maternal Exposure
Pregnancy
Prenatal Exposure Delayed Effects - chemically induced
Prenatal Exposure Delayed Effects - diagnosis
Prenatal Exposure Delayed Effects - epidemiology
Research paper
Risk Factors
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Childhood leukemia etiology, and mainly the interactions of genetic and environmental risk factors, remains largely unexplored. This national hospital-based case–control study was carried out in Brazil among children aged 0–23 months who were recruited at cancer and general hospitals in 13 states. Maternal medicine intake during pregnancy, including analgesic intake, was assessed by face-to-face interviews with the mothers of 231 leukemia patients and 411 controls. Unconditional logistic regression was used to ascertain crude and adjusted odds ratios (ORs), and their 95% confidence intervals (CIs) for the association between maternal analgesic use during pregnancy and early age leukemia. Acetaminophen use during the first trimester of pregnancy showed an OR=0.39 (95% CI 0.17–0.93) for acute lymphocytic leukemia and an OR=0.37 (95% CI 0.16–0.88) for use in the second trimester. For acute myeloid leukemia, an OR=0.11 (95% CI 0.02–0.97) was found following acetaminophen use in the second trimester. For acute lymphocytic leukemia, the exclusive use of dipyrone during preconception showed an OR=1.63 (95% CI 1.06–2.53) and dipyrone intake during lactation showed an OR=2.00 (95% CI 1.18–3.39). These results suggest that acetaminophen use during pregnancy may protect against development of early age leukemia in the offspring, whereas dipyrone use may act as a risk factor for such an outcome.
ISSN:0959-8278
1473-5709
DOI:10.1097/CEJ.0000000000000070